Literature DB >> 2466892

A monoclonal antibody raised to lipomodulin recognizes T suppressor factors in two independent hapten-specific suppressor networks.

J K Steele1, V K Kuchroo, H Kawasaki, S Jayaraman, M Iwata, K Ishizaka, M E Dorf.   

Abstract

Five different Ag-binding suppressor factors from two types of hapten-specific Ts cell hybridomas (TsF1 inducer and TsF3 effector factors) were bound by an anti-lipomodulin mAb (141-B9), that crossreacts with rodent glycosylation inhibition factor (GIF). The Ag-specific suppressor activity in these hybridoma supernatants was bound by anti-lipomodulin columns and could be recovered by elution at acid pH. Additional evidence for the expression of lipomodulin/GIF activity on these TsF molecules was demonstrated by the ability of the eluted fractions to inhibit the glycosylation of IgE-binding peptides during their biosynthesis. The same biologic activity is associated with GIF and lipomodulin. The relationship between TsF and lipomodulin/GIF was confirmed in a serologic assay, which showed that TsF1 and TsF3 molecules, whether purified over Ag, anti-IJ or anti-TsF columns, are recognized by the mAb. 141-B9. The combined results indicate that Ag-binding Ts factors share a common antigenic determinant with phospholipase inhibitory proteins such as lipomodulin and GIF. In addition, the demonstration of glycosylation regulatory activity carried on these TsF molecules suggests a possible mode for their bioactivity.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2466892

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

1.  Cellular mechanisms for the formation of a soluble form derivative of T-cell receptor alpha chain by suppressor T cells.

Authors:  Y Ishii; T Nakano; K Ishizaka
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

2.  Biochemical identification of glycosylation inhibiting factor.

Authors:  K Katamura; M Iwata; A Mori; K Ishizaka
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

3.  Cloning and mapping of the mouse glycosylation-inhibiting factor gene and four related genes.

Authors:  N Honma; Y Matsuda; Y Ishii; M Sato; T Tomura; N Yuyama; T Mikayama
Journal:  Mamm Genome       Date:  1996-01       Impact factor: 2.957

4.  Comparison of T suppressor factors from tumour-bearing mice and mice immunized with a monoclonal anti-idiotypic antibody.

Authors:  J M Greer; W J Halliday
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

5.  Characterization of the macrophage subset affected and its response to a T suppressor factor (TsFmp) found in cryptococcosis.

Authors:  R Blackstock; N C Hernandez
Journal:  Infect Immun       Date:  1989-10       Impact factor: 3.441

6.  Biochemical characterization of murine glycosylation-inhibiting factor.

Authors:  Y Tagaya; A Mori; K Ishizaka
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-15       Impact factor: 11.205

7.  Molecular cloning and functional expression of a cDNA encoding glycosylation-inhibiting factor.

Authors:  T Mikayama; T Nakano; H Gomi; Y Nakagawa; Y C Liu; M Sato; A Iwamatsu; Y Ishii; W Y Weiser; K Ishizaka
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

8.  The role of complement component C3b and its receptors in sperm-oocyte interaction.

Authors:  D J Anderson; A F Abbott; R M Jack
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

9.  Requirement of posttranslational modifications for the generation of biologic activity of glycosylation-inhibiting factor.

Authors:  Y C Liu; T Nakano; C Elly; K Ishizaka
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-08       Impact factor: 11.205

10.  Antigen-binding glycosylation inhibiting factor from a human T-cell hybridoma specific for bee venom phospholipase A2.

Authors:  H Gomi; Y Tagaya; T Nakano; T Mikayama; K Ishizaka
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-29       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.